News & Resources
Patent Office Improves Examination of Software Patent Applications
Posted on May 31, 2018 in News
Explanation. When the U.S. government denies us legal protection, we want to know why. Accompanying an adverse decision […]
Read MoreCohen Quoted on Value of Trademarks
Posted on May 30, 2018 in News
Stanley H. Cohen was recently interviewed for an article entitled, “Is a Trademark Worth the Cost?”, which was […]
Read MoreU.S. Supreme Court Tackles Overseas Damages for US Patent Infringement
Posted on May 9, 2018 in Articles
The U.S. Supreme Court has rarely addressed the issue of patent damages, but a case currently before the […]
Read MoreWhat to Do When the Patent Office Says ‘No’
Posted on Mar 28, 2018 in Articles
According to the U.S. Supreme Court, a patent application is one of the most difficult legal instruments that can be drafted. Small wonder that most patent applications are initially rejected by the Patent Office. Although negotiating with the Patent Office examiner, including presenting amendments and arguments often will lead to a patent application being issued as a U.S. patent, there are times when no amount of effort will translate into success.
Read MoreCourt Applies ‘Chevron’ Deference to Patent Law in ‘Fractured’ Decision
Posted on Feb 21, 2018 in Articles
It is unusual for the Federal Circuit to apply the doctrine of Chevron deference to patent law, but a recent decision is noteworthy—and fractured.
Read MoreSeveral Steps to Improve Your Patent Strategy in 2018
Posted on Jan 25, 2018 in Articles
If the survival and growth of your business depends on the development of new technology, the beginning of the new year is a good time to think about your intellectual property (IP) protection and how it can be improved.
Read MoreThe Hottest Patent Law Issues of 2017
Posted on Jan 8, 2018 in Articles
As we start the new year, let’s look back at the most important patent law opinions of 2017.
Read MoreControversial Strategy: Selling Patents to a Native American Tribe
Posted on Dec 4, 2017 in Articles
Allergan (a pharmaceutical company) is the manufacturer of Restasis, a prescription eye drop that is used to treat Chronic Dry Eye disease by increasing tear production. Restasis has been a commercial success, with sales in 2016 of approximately $1.5 billion, and Allergan’s website states that its formulation has been “prescribed 6.4 million times since 2003.” Restasis is patented, and those patents received significant attention last month when they were sold to a Native American tribe—as a litigation strategy.
Read MoreCR Partner Appointed Co-Chair of Printing-for-Digital Fabrication Conference
Posted on Nov 9, 2017 in News
CR Partner Scott Slomowitz has been appointed publicity co-chair for the Printing-for-Digital Fabrication Conference, sponsored by the Society for Imaging Science and Technology, to be held in Dresden, Germany in September 2018.
Read MoreDon’t Let Your Trademark Become Generic
Posted on Oct 25, 2017 in Articles
A music video went viral this month, but it’s doubtful you know any of its musicians. The tune is quite catchy, and the performance is not only professional, but very enjoyable. What is the theme of the song? Coming of age? A broken heart? No. It’s a music video about Velcro Brand Fasteners and the VELCRO trademark.
Read More